Stem Cell Therapies Will Bring Transformational Returns

The Penny Sleuth Features: Penny Stocks, Options and High-Growth Opportunities! Stem Cell Therapies Will Bring Transformational Returns By Ray Blanco March 28, 2011 Dear Penny Sleuther, Stem cells are simply too important for an investor to ignore. In biotechnology, no field is more transformational or disruptive than stem cell science. Stem cells alone have the power to regenerate new, biologically young, tissue. When diseased cells, from hearts to brains, can be routinely regenerated, the quality and length of life will improve dramatically. WARNING: This is Controversial. It Offends "Gloom and Doomers" Here's why it's NOT the end of America... Shocking new presentation reveals epic opportunities - viewer discretion advised for thin-skinned fear mongers. Watch the presentation right here... There is more to it than that, of course. Our bodies constantly regenerate without the help of external stem cell-based therapies. All those endogenously regenerated tissues, however, have the same defect. The new cells are all biologically older than their predecessors. As we age, our regenerative powers wane. In certain tissues, such as those of the brain and nervous system, the power to restore complete function in the case of an injury simply isn't there. We know for a fact that this is not the case in all living things. There are animals, like the lobster, that do not go through telomere shortening. Functionally, their cells are immortal -- at least until they get eaten by another organism. The ends of the DNA strands are to blame, as you know. With the exception of our reproductive cells, every time a cell divides, the "caps" on the ends of those strands get a little bit shorter. Called telomeres, these DNA caps eventually get too short. Normally, unless the telomeres are lengthened, this is the end of the cell line. Wealth Revelations: Historic Profit Potential from Just-Released Research The blind will see again. The sick will be healthy again. Four tiny companies could make these miracles a reality. For a chance at the biggest possible profits - you must read this shocking report immediately. There isn't much time for you to act... Telomeres, in a sense, are like candles. Early on, after being lit with the fire of new life, our cellular "candles" are long. Over time, however, they "burn down" and shorten. Eventually, they become too short, and the fire snuffs out. We age and die. Needless to say, a technology with the potential to considerably lengthen life spans will be met with resistance. Despite futile searches for fountains of youth in the Florida wilderness and alchemical attempts to discover philosopher's stones, nothing like this has ever existed in history. Psychological factors make people resistant to changes in the status quo. The effects on society will be enormous. For one thing, a Social Security system designed at a time when the average life expectancy was in the mid-60s will need either drastic reform or it will collapse. We see this resistance to change at play in genetically modified food crops, for example. Plants with improved traits, such as disease and drought resistance, can improve yields and make life dramatically better for millions of people on the edge of starvation. However, GM crops are strongly opposed by a segment of the population that views genetic engineering as a crime against nature. Why Waste Time and Money on Blue Chips? All the great investors know the real profits are in these hidden stocks that no one talks about. Hot biotech plays are just the start. Take a look at what the CXS Money Multiplier can do for your investments. Click here for a FREE presentation... This is nothing new. At one time, for example, the administration of anesthesia to birthing women was widely opposed. That is not the case today. The benefits are too great. Up until a fraudulent scientific study ignited opposition in the late 1990s, this was also the case with vaccines. There was tremendous resistance to vaccinations in the early 1900s. This technology, however, has saved hundreds of millions of lives in the last 100 years. Other than those that buy into the vaccine scare, everybody receives the immune boosting benefits. Stem cell therapies have opponents, too. However, I suspect that when the benefits of stem cell therapies become apparent to the public at large, we will see resistance decline as well. In addition, thanks to recent discoveries on how to turn adult cells into stem cells, many of the ethical barriers to their use are being cleared away. These alternatives are making embryonic stem cells obsolete. In time, we will take the cures for granted. Thanks to vaccination technology, we take for granted that polio no longer paralyzes children today. Likewise, we will one day find it hard to imagine a world where a spinal cord injury could leave an otherwise healthy person paralyzed for the rest of their life. Stem cell therapies will also, of course, yield profits that will be unmatched in investing history. There is no surer way to make transformational returns over the long run than investing in transformational technology. Ad lucrum per scientia (toward wealth through science), Ray Blanco Why It's NOT the End of America... This is actually the greatest moment to be alive - and to grow incredibly wealthy. Warning: What you're about to see is controversial. It will offend the "Gloom & Doom Crowd". Watch this urgent presentation now. Stem Cell Therapies Will Bring Transformational Returns is featured at Penny Sleuth. The Secret $200 Retirement Blueprint Investing in Penny Stocks What Is Technical Trading Follow the Penny Sleuth on Twitter, here. Become a Facebook Fan of The Penny Sleuth, here. The Penny Sleuth, a free e-letter, offers independent news and commentary on small cap stocks, options and high growth opportunities. We sent this e-mail to KNUMASSCN@gmail.com because you or someone using your e-mail address subscribed to this service. Are you having trouble receiving your Penny Sleuth? You can ensure its arrival in your mailbox by: Whitelisting Penny Sleuth. To end your Penny Sleuth e-mail subscription, click: Unsubscribe. The Penny Sleuth is your free and independent source for analysis, commentary and news on small cap stocks, options and high growth opportunities. At the Penny Sleuth, we give your our 100% independence pledge. That means that we never receive compensation to talk about any stocks we feature. Our editorial staff never owns a position in any of the stocks we mention at the time of publication. And we only recommend stocks that we come across in our own original research. Our pledge also means that we won't collaborate with companies who don't live up to our independence requirements. Nothing in this e-mail should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. © 2011 Agora Financ ial, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the World Wide Web), in whole or in part, is strictly prohibited without the express written permission of Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202.